Clinical Trial Update: Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on low dose prednisone therapy for women with recurrent pregnancy loss, currently in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage
• Pregnancy Loss

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Soroka University Medical Center | Conditions: Recurrent Pregnancy Loss(RPL), Recurrent Miscarriage | Phase 2, Phase 3 | Status: UNKNOWN